Assessment of a potential new treatment option for patients with metastatic gastrointestinal stromal tumor (GIST) that may overcome resistance to established compounds
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ‐HN43: Phase IV (2019 - Journal of the Sciences and Specialities of the Head & Neck)
Addressing the dichotomy between individual and societal approaches to personalized medicine in oncology (2019 - European Journal of Cancer)
The EORTC Cancer Research Fund aims to raise funds to support the independent academic cancer research activities of the EORTC.
The EORTC invites you to support the manifesto on Treatment Optimisation. Please confirm your support before the 28th Feb. 2019.